Rankings
▼
Calendar
LGVN Q4 2024 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$20M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$603,000
+857.1% YoY
Gross Profit
$530,000
87.9% margin
Operating Income
-$4M
-710.0% margin
Net Income
-$4M
-676.8% margin
EPS (Diluted)
$-0.27
QoQ Revenue Growth
-22.0%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$26M
Total Liabilities
$4M
Stockholders' Equity
$22M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$603,000
$63,000
+857.1%
Gross Profit
$530,000
-$2,000
+26600.0%
Operating Income
-$4M
-$5M
+21.3%
Net Income
-$4M
-$6M
+32.3%
← FY 2024
All Quarters
Q1 2025 →